These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7640544)

  • 1. Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.
    Gourlay SG; Forbes A; Marriner T; Pethica D; McNeil JJ
    BMJ; 1995 Aug; 311(7001):363-6. PubMed ID: 7640544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation.
    Gourlay SG; Forbes A; Marriner T; Pethica D; McNeil JJ
    BMJ; 1994 Oct; 309(6958):842-6. PubMed ID: 7950614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal nicotine patches with low-intensity support to aid smoking cessation in outpatients in a general hospital. A placebo-controlled trial.
    Foulds J; Stapleton J; Hayward M; Russell MA; Feyerabend C; Fleming T; Costello J
    Arch Fam Med; 1993 Apr; 2(4):417-23. PubMed ID: 8130921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group.
    Daughton D; Susman J; Sitorius M; Belenky S; Millatmal T; Nowak R; Patil K; Rennard SI
    Arch Fam Med; 1998; 7(5):425-30. PubMed ID: 9755734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
    Russell MA; Stapleton JA; Feyerabend C; Wiseman SM; Gustavsson G; Sawe U; Connor P
    BMJ; 1993 May; 306(6888):1308-12. PubMed ID: 8518572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.
    JAMA; 1991 Dec; 266(22):3133-8. PubMed ID: 1956099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
    Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
    Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.
    Davidson M; Epstein M; Burt R; Schaefer C; Whitworth G; McDonald A
    Arch Fam Med; 1998; 7(6):569-74. PubMed ID: 9821833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a nicotine patch in helping people stop smoking: results of a randomised trial in general practice. Imperial Cancer Research Fund General Practice Research Group.
    BMJ; 1993 May; 306(6888):1304-8. PubMed ID: 8518571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal nicotine patches on ambulatory ECG monitoring findings: a double-blind study in healthy smokers.
    Khoury Z; Comans P; Keren A; Lerer T; Gavish A; Tzivoni D
    Cardiovasc Drugs Ther; 1996 May; 10(2):179-84. PubMed ID: 8842510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight change after smoking cessation using variable doses of transdermal nicotine replacement.
    Dale LC; Schroeder DR; Wolter TD; Croghan IT; Hurt RD; Offord KP
    J Gen Intern Med; 1998 Jan; 13(1):9-15. PubMed ID: 9462489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.